Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks

被引:0
作者
Longhurst, Hilary [1 ]
Aberer, Werner [2 ]
Bouillet, Laurence [3 ]
Caballero, Teresa [4 ]
Fabien, Vincent [5 ]
Kanny, Gisele [6 ]
Zanichelli, Andrea [7 ]
Maurer, Marcus [8 ]
机构
[1] Barts & London Hosp, London, England
[2] Med Univ Graz, Graz, Austria
[3] Grenoble Univ Hosp, Grenoble, France
[4] Hosp La Paz Res Ctr IdiPaz, Madrid, Spain
[5] Shire Human Genet Therapies, Eysins, Switzerland
[6] Univ Lorraine, Vandoeuvre Les Nancy, France
[7] Luigi Sacco Univ Milan, Milan, Italy
[8] Charite, D-13353 Berlin, Germany
关键词
D O I
10.1016/j.jaci.2012.12.798
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB33 / AB33
页数:1
相关论文
共 50 条
[21]   Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey [J].
Andresen, Irmgard ;
Longhurst, Hilary ;
Aberer, Werner ;
Bouillet, Laurence ;
Caballero, Teresa ;
Grumach, Anete S. ;
Maurer, Marcus ;
Botha, Jaco ;
Zanichelli, Andrea .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) :AB44-AB44
[22]   EARLY ICATIBANT TREATMENT IS ASSOCIATED WITH FASTER RESOLUTION OF HEREDITARY ANGIOEDEMA ATTACKS: REAL-WORLD DATA FROM THE ICATIBANT OUTCOME SURVEY [J].
Longhurst, H. ;
Caballero, T. ;
Zanichelli, A. ;
Aberer, W. ;
Fabien, V. ;
Bouillet, L. ;
Maurer, M. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) :A47-A48
[23]   Self-administration of icatibant to treat hereditary angioedema in four patients with moderate to severe attacks [J].
Abajian, M. ;
Doumoulakis, G. ;
Agnieszka, M. ;
Schoepke, N. ;
Maurer, M. ;
Magerl, M. .
ALLERGY, 2012, 67 :353-353
[24]   ICATIBANT FOR HEREDITARY ANGIOEDEMA [J].
Gras, Jordi .
DRUGS OF TODAY, 2009, 45 (12) :855-864
[25]   A study of the safety, tolerability and efficacy of self-administration of icatibant for acute attacks of hereditary angioedema [J].
Aberer, W. ;
Wiednig, M. ;
Reshef, A. ;
Nair, N. ;
Lachmann, A. ;
Hoch, B. ;
Bloom, B. ;
Longhurst, H. ;
Maurer, M. ;
Kivity, S. ;
Malbran, A. .
ALLERGY, 2011, 66 :80-80
[26]   Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study [J].
Yang W. ;
Hébert J. ;
Ritchie B. ;
Baptista J. ;
Riedl M. ;
Lumry W.R. .
Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
[27]   Audit of the treatment of attacks of hereditary angioedema with icatibant in two United Kingdom immunology departments [J].
Bright, P. ;
Longhurst, H. ;
Dempster, J. .
ALLERGY, 2011, 66 :430-431
[28]   Treatment of Hereditary Angioedema Attacks with Icatibant: A Comparison of Observational Data with Clinical Trial Data [J].
Maurer, Marcus ;
Longhurst, Hilary ;
Li, Huamin Henry ;
Fabien, Vincent ;
Lumry, William R. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) :AB32-AB32
[29]   Management of acute attacks of hereditary angioedema: potential role of icatibant [J].
Longhurst, Hilary J. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 :795-802
[30]   REINJECTION OF ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS: RESULTS FROM AN ANALYSIS OF MORE THAN 2000 ATTACKS [J].
Andresen, I. ;
Longhurst, H. J. ;
Aberer, W. ;
Bouillet, L. ;
Caballero, T. ;
Fabien, V. ;
Zanichelli, A. ;
Maurer, M. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) :A114-A115